FDA Authorizes OPKO Health Clinical Trial Evaluating RAYALDEE in COVID-19 Patients
MIAMI, June 01, 2020 (GLOBE NEWSWIRE) — OPKO Health, Inc. (NASDAQ: OPK) today announced that the U.S. Food and Drug […]
Lightbridge Awarded Patent in Eurasia for Innovative Nuclear Fuel Assemblies
RESTON, Va., June 01, 2020 (GLOBE NEWSWIRE) — Lightbridge Corporation (NASDAQ: LTBR), an advanced nuclear fuel technology company, today announced […]
Infinera Appoints George Riedel and Christine Bucklin to Board of Directors, Increasing Board Size to 11
SUNNYVALE. Calif., June 01, 2020 (GLOBE NEWSWIRE) — Infinera (NASDAQ: INFN) announced today the appointment of George Riedel and Christine […]
Chuy’s Holdings, Inc. Provides Business Update
AUSTIN, Texas, June 01, 2020 (GLOBE NEWSWIRE) — Chuy’s Holdings, Inc. (NASDAQ:CHUY) today provided a business update in light of […]
Mayo Clinic joins Biomerica’s InFoods® Irritable Bowel Syndrome (“IBS”) Diagnostic-Guided Therapy clinical trial
Biomerica also announces its first Japanese patent has been granted for its InFoods® IBS Diagnostic Guided Therapy technologyInFoods® Diagnostic-Guided Therapy […]
WillScot Announces $500 Million Senior Secured Notes Offering
BALTIMORE, June 01, 2020 (GLOBE NEWSWIRE) — WillScot Corporation (Nasdaq: WSC) (“WillScot”), a specialty rental services market leader providing innovative […]
MUSCLE MAKER GRILL TO OPEN FOUR LOCATIONS AT NORTHERN VIRGINIA COMMUNITY COLLEGE
Healthier for you brand signs lease for four NOVA community college locationsBurleson, TX, June 01, 2020 (GLOBE NEWSWIRE) — Muscle […]
Primoris Services Corporation Announces Solar Award
DALLAS, June 01, 2020 (GLOBE NEWSWIRE) — Primoris Services Corporation (NASDAQ Global Select: PRIM) (“Primoris” or “Company”) today announced the […]
Strongbridge Biopharma plc to Present at the Jefferies Virtual Healthcare Conference
DUBLIN, Ireland and TREVOSE, Pa., June 01, 2020 (GLOBE NEWSWIRE) — Strongbridge Biopharma plc (Nasdaq: SBBP), a global commercial-stage biopharmaceutical […]
Aileron Therapeutics Announces Positive Interim Results from Phase 1b/2 Clinical Trial of ALRN-6924 for the Prevention of Topotecan-induced Toxicities During Treatment for Small Cell Lung Cancer
– – –Observed a protective effect against severe chemotherapy-induced anemia and thrombocytopenia across all dose levels– – –Management to host […]
